Articles published by Axsome Therapeutics, Inc.
Via GlobeNewswire
Tickers
AXSM
Via GlobeNewswire
Tickers
AXSM

Via GlobeNewswire
Tickers
AXSM

Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Hetero Labs Ltd.
May 27, 2025
Via GlobeNewswire
Tickers
AXSM
Via GlobeNewswire
Tickers
AXSM
Via GlobeNewswire
Tickers
AXSM
Via GlobeNewswire
Tickers
AXSM



Axsome Therapeutics to Participate in Upcoming Investor Conferences
February 26, 2025
Via GlobeNewswire
Tickers
AXSM


Axsome Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 18, 2025
Via GlobeNewswire
Tickers
AXSM


Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
January 31, 2025
Via GlobeNewswire
Tickers
AXSM


Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18
January 22, 2025
Via GlobeNewswire
Tickers
AXSM

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue
January 13, 2025
Via GlobeNewswire
Tickers
AXSM
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.